Alejandro Weinstein, Chairman of Pluri, shares insights on the future of biotechnology and cell-based therapies. Weinstein ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

A Chicago doctor is using new FDA-approved technology that makes cancer cells glow during surgery. Here's how it works.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

The MarketWatch News Department was not involved in the creation of this content. The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing ...

Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Find out which Indian University was the first to teach biotechnology and why it was important for science and education in India.